Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of the AVAglio trial - Sandmann, Thomas; Wick, Wolfgang (Journal of clinical oncology, 2015)
Gesehen am 19.12.2016